Novel coronavirus infection (COVID-19) in a 12-year-old boy with acute lymphoblastic leukemia Marhaeni W, Abdiwati NM, Wijaya AB, - J Indian Prosthodont Soc

Editorial board

CASE REPORT

Ahead of Print

Novel coronavirus infection (COVID-19) in a 12-year-old boy with acute lymphoblastic leukemia Wulandewi Marhaeni¹, Ni Made Yuliari Abdiwati², Andreas Budi Wijaya³ ¹ Department of Pediatrics, Hematology-Oncologym Division, Faculty of Medicine, Ulin General Hospital, Lambung Mangkurat University, Banjarmasin, South Kalimantan, Indonesia ² Department of Pediatrics of Doris Sylvanus Hospital, Palangkaraya, Central Kalimantan, Indonesia ³ Department of Pediatrics of Ulin General Hospital, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, South Kalimantan, Indonesia Correspondence Address: Wulandewi Marhaeni, Department of Pediatrics of Ulin General Hospital, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, South Kalimantan Indonesia Source of Support: None, Conflict of Interest: None DOI: 10.4103/jcrt.JCRT_653_20

Pediatric acute lymphoblastic leukemia (ALL) with COVID-19 might still have a risk of severe infection due to immunocompromised condition. The clinical features in oncology population are quite similar to those of previous reports in general pediatric cases. Chemotherapy should be arranged individually to balance the risk between leukemia progressivity itself and COVID-19 complications. Interruptions of therapy must be thought in cases with severe or symptomatic infection of severe acute respiratory syndrome-CoV-2. In this case report, chemotherapy will be started 1 week after the improvement of general condition. Chemotherapy should not be postponed for >14 days.

  Search Pubmed for

    -  Marhaeni W
    -  Abdiwati NM
    -  Wijaya AB

Citation Manager

Article Access Statistics

Reader Comments

* Requires registration (Free)

Article Access Statistics

Viewed	327

PDF Downloaded	7